Plasma Proteins Market to Hit USD 53.24 Billion by 2030

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Plasma Proteins Market- by Product Type (Coagulation factors, Immunoglobulin, Alpha-1 proteinase inhibitor and Albumin), Application (Hemophilia, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema and Primary Immunodeficiency Disorder), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1098

According to the latest research by InsightAce Analytic, the global Plasma Proteins market is valued at US$ 26.0 Billion in 2021. It is expected to reach US$ 53.24 Billion by 2030, with a CAGR of 8.56% during a forecast period of 2022-2030.

Plasma, a clear, straw-colored fluid, is the component of blood that remains after the removal of red blood cells, white blood cells, platelets, and other biological elements. Human blood contains various proteins, including plasma proteins, which consist of simple proteins, glycoproteins, and conjugated proteins such as lipoproteins. Plasma protein therapies are used to address specific medical conditions by replacing deficient or missing proteins in plasma. These therapies, which are classified as biological drugs, are administered through infusion or injection to treat life-threatening, chronic, and hereditary diseases. Plasma proteins also play a critical role in the blood clotting process and contribute to immune defense against diseases.

The global plasma protein market is primarily driven by the increasing use of plasma-derived pharmaceuticals and the introduction of innovative plasma-based therapeutics. Additional growth factors include the rising prevalence of neurological and immunological disorders, along with infectious diseases such as varicella, rabies, tetanus, and hepatitis A and B. However, market expansion faces certain challenges, including stringent government regulations, reimbursement complexities, and the technical challenges associated with biologics manufacturing. Advances in protein fractionation technology have improved both the efficiency and cost-effectiveness of plasma protein extraction, which is expected to further boost market demand. Moreover, increasing public awareness about blood donation and supportive government initiatives are anticipated to contribute to the market's significant growth in the coming years.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

North America is expected to be a key contributor to the plasma proteins market. The region's growth is primarily driven by the presence of a large patient population, an expanding elderly demographic, and a well-established infrastructure for the collection and storage of high-quality source plasma. Furthermore, the Asia Pacific plasma proteins market is projected to experience significant growth over the forecast period. Key factors driving this growth include a well-developed healthcare infrastructure, increased focus by market participants on research and development for plasma protein therapies, the introduction of new products, and the rising incidence of autoimmune diseases in the region.

Major market players operating in the Plasma Proteins market include
Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline and Other Key Players

Recent collaborations and agreements in the market:
• In March 2022, Rika Plasma Donation System (Rika), a new plasma collection system created by medical technology company Terumo Blood and Cell Technologies (Terumo BCT), received FDA approval. Rika is a cutting-edge automated system focusing on the experience of donors and staff in plasma centers.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1098

Market Segments
Global Plasma Proteins Market, by Product Type, 2022-2030 (Value US$ Mn)
• Coagulation factors
• Immunoglobulin
• Alpha-1 proteinase inhibitor
• Albumin
Global Plasma Proteins Market, by Application, 2022-2030 (Value US$ Mn)
• Hemophilia
• Idiopathic Thrombocytopenic Purpura
• Secondary Immunodeficiency
• Hereditary Angioedema
• Primary Immunodeficiency Disorder
Global Plasma Proteins Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Plasma Proteins Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Plasma Proteins Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Plasma Proteins Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Plasma Proteins Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Plasma Proteins Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Plasma Proteins market
 To receive an industry overview and future trends of the Plasma Proteins market
 To analyze the Plasma Proteins market drivers and challenges
 To get information on the Plasma Proteins market value (US$ Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Plasma Proteins market industry

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.